Cargando…
Metadherin–PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT–β-catenin signaling pathway
Accumulating data suggest that metadherin (MTDH) may function as an oncogene. Our previous study showed that MTDH promotes hepatocellular carcinoma (HCC) metastasis via the epithelial-mesenchymal transition. In this study, we aim to further elucidate how MTDH promotes HCC metastasis. Using Co-immuno...
Autores principales: | Zhu, Kai, Peng, Yuanfei, Hu, Jinwu, Zhan, Hao, Yang, Liuxiao, Gao, Qiang, Jia, Hao, Luo, Rongkui, Dai, Zhi, Tang, Zhaoyou, Fan, Jia, Zhou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175245/ https://www.ncbi.nlm.nih.gov/pubmed/31498866 http://dx.doi.org/10.1093/carcin/bgz065 |
Ejemplares similares
-
Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma
por: Zhu, Kai, et al.
Publicado: (2020) -
PRMT1 loss sensitizes cells to PRMT5 inhibition
por: Gao, Guozhen, et al.
Publicado: (2019) -
Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis
por: Ortiz-Soto, Gabriela, et al.
Publicado: (2023) -
The expression of myogenic microRNAs indirectly requires protein arginine methyltransferase (Prmt)5 but directly requires Prmt4
por: Mallappa, Chandrashekara, et al.
Publicado: (2011) -
MicroRNA-466 inhibits the aggressive behaviors of hepatocellular carcinoma by directly targeting metadherin
por: Jia, Chen, et al.
Publicado: (2022)